Literature DB >> 23006973

Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

Ignace Vergote1, Andreas du Bois2, Frederic Amant3, Florian Heitz2, Karin Leunen3, Philipp Harter2.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23006973     DOI： 10.1016/j.ygyno.2012.09.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  26 in total

1.  Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy.

Authors:  Seiya Sato; Hiroaki Itamochi
Journal:  Ther Adv Med Oncol       Date:  2014-11       Impact factor: 8.168

2.  Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study.

Authors:  Katrijn L M Michielsen; Ignace Vergote; Raphaëla Dresen; Katya Op de Beeck; Ragna Vanslembrouck; Frédéric Amant; Karin Leunen; Philippe Moerman; Steffen Fieuws; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Br J Radiol       Date:  2016-09-21       Impact factor: 3.039

3.  Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution.

Authors:  Inga Steinberga; Kjell Jansson; Bengt Sorbe
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

Review 4.  Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients.

Authors:  Lucas Minig; Cristina Zorrero; Pablo Padilla Iserte; Andres Poveda
Journal:  World J Methodol       Date:  2015-12-26

5.  Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm.

Authors:  Ashley L Cole; Emma L Barber; Anagha Gogate; Arthur-Quan Tran; Stephanie B Wheeler
Journal:  Int J Gynecol Cancer       Date:  2018-07       Impact factor: 3.437

6.  The outcomes of intestinal resection during debulking surgery for ovarian cancer.

Authors:  Serdar Gökay Terzioğlu; Murat Özgür Kılıç; Nilüfer Çetinkaya; Eralp Baser; Tayfun Güngör; Cevdet Adıgüzel
Journal:  Turk J Surg       Date:  2017-06-01

7.  Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer.

Authors:  Roelien van de Vrie; Marianne J Rutten; Joyce Danielle Asseler; Mariska Mg Leeflang; Gemma G Kenter; Ben Willem J Mol; Marrije Buist
Journal:  Cochrane Database Syst Rev       Date:  2019-03-23

8.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Authors:  Katrijn Michielsen; Ignace Vergote; Katya Op de Beeck; Frederic Amant; Karin Leunen; Philippe Moerman; Christophe Deroose; Geert Souverijns; Steven Dymarkowski; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Eur Radiol       Date:  2013-12-11       Impact factor: 5.315

Review 9.  Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States.

Authors:  Ashley L Cole; Anna E Austin; Ryan P Hickson; Matthew S Dixon; Emma L Barber
Journal:  Cancer Epidemiol       Date:  2018-05-25       Impact factor: 2.984

10.  18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer.

Authors:  Tuulia Vallius; Johanna Hynninen; Jukka Kemppainen; Victor Alves; Kari Auranen; Jaakko Matomäki; Sinikka Oksa; Johanna Virtanen; Seija Grénman; Annika Auranen; Marko Seppänen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-23       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.